NSE IPO Exchange Eyes Early June Filing with Securities Regulator Bessent Sees Substantial Disinflation Ahead as Warsh Takes Over the Fed Aramco Divests Malaysia Refining Complex in Strategic Transfer to Petronas The Federal Reserves Path to Rate Cuts Narrows Amid Stubborn Cost of Living Pressures White House Touts Soybean and Rare Earths Deals Following TrumpXi Summit as China Signals Tariff Reductions Sensex Surges Over 850 Points Nifty Approaches 24000 as IranUS Deal Hopes Drive Crude Oil Plunge MDXG Q1 2026 Earnings EPS Misses Estimates as GAAP Loss Widens NTSK Q4 2025 Earnings Narrowed Loss and Positive Market Sentiment National Vision Holdings EYE Q1 2026 Earnings EPS Surprise Lifts Stock After Revenue Shortfall BBGI Q4 2025 Earnings Significant Loss Reported Stock Rises 415 NG Q1 2026 Earnings Narrowed Loss Beat Estimates as Donlin Gold Project Advances SACH Q1 2026 Earnings Steep EPS Miss Highlights Challenges Stock Gains First Watch Restaurant Group Holds Steady Near Support After Modest Gain Ready Capital Corporation RC Rebounds 281 as Stock Finds Support Near 174 Invesco Mortgage Capital IVR Edges Lower Amid Broader Mortgage REIT Pressure Wave Life Sciences WVE Holds Steady Near Key Support Amid Modest Decline Agilent Technologies A Holds Steady as Stock Trades Near Midpoint of Trading Range Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement SCLX Q1 2026 Earnings Net Loss Widens as Pipeline Progress Drives Stock Higher Li Bang International LBGJ Hovers Near Support Amid Modest Decline Barings BDC Inc BBDC Q1 2026 Earnings Net Investment Income Misses Estimates as Portfolio Holds Steady Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported TPR Q1 2026 Earnings EPS Exceeds Estimates by 26 RILYP Q1 2024 Earnings Preferred Shares Report Negative EPS Amid No Revenue or Estimate Astec Industries Q1 2026 Earnings EPS Miss Sends Shares Lower MFAO Q1 2026 Earnings Narrow Earnings Miss Reflects Stable mREIT Performance SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development